Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 826-829, 2003; 10.1373/49.5.826
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jeong, S. Y.
Right arrow Articles by Choi, E. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jeong, S. Y.
Right arrow Articles by Choi, E. Y.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2003;49:826-829.)
© 2003 American Association for Clinical Chemistry, Inc.


Technical Briefs

Sandwich ELISA for Measurement of Cytosolic Aspartate Aminotransferase in Sera from Patients with Liver Diseases

So Young Jeong1, Kwang Joong Kim1, Dong Joon Kim2, Sang Wook Oh1 and Eui Yul Choi1,3,a

1 Central Research Institute, Boditech Inc., Chuncheon, South Korea 200-160
Departments of
2 Internal Medicine and
3 Genetic Engineering, Hallym University, Chuncheon, South Korea 200-702

aauthor for correspondence: fax 82-33-258-6889, e-mail euichoi@hallym.ac.kr

The first 20% of the full text of this article appears below.

With the introduction of modern biochemical techniques, more than 50 enzymes have been developed for diagnostics in liver tests. Among the enzymes, aspartate aminotransferase (AST; EC 2.6.1.1; formerly known as GOT) was introduced in the mid-1950s and has remained the mainstay of enzyme diagnosis for liver disease for more than half a century (1). AST is widely distributed among human organs as cytosolic and mitochondrial isotypes (2). Increased activity of this enzyme is considered one of the most sensitive indicators of hepatocellular damage (3). Previously, several attempts were made to develop an immunoassay procedure for measuring AST mass rather than enzyme activity, but they are currently not used for the diagnosis of liver diseases (4)(5)(6)(7)(8). In this study, we generated monoclonal antibodies (mAbs) to AST and used them to develop a sandwich ELISA to measure the enzyme mass in sera.

Because the amino acid sequences of the human and porcine enzymes are similar, we used porcine AST as an immunogen for the production of mAbs (9). The porcine enzyme is commercially available as a highly purified form in large quantities. Twenty hybridoma cells to porcine AST were initially screened by ELISA from several fusions, and four clones were selected for further characterization.

To confirm the specificity of the mAbs to the human enzyme, we immunoblotted partially purified human enzyme and total proteins extracted from a human liver with the mAbs. The antibodies specifically recognized a single protein band of 45 kDa, which coincided well with the expected size of AST. To evaluate whether the mAbs recognized a cytosolic or . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.